The Cooper Companies, Inc. (COO) Insider Trading Activity

NASDAQ$76.55
Market Cap
$15B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
101 of 883
Rank in Industry
4 of 49

COO Insider Trading Activity

COO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,520,761
10
100
Sells
$0
0
0

Related Transactions

White Albert G IIIPresident & CEO
2
$1.49M
0
$0
$1.49M
Kurzius Lawrence Erikdirector
2
$301,780
0
$0
$301,780
McBride Daniel GEVP & Chief Operating Officer
1
$195,120
0
$0
$195,120
Lucchese Cynthia Ldirector
1
$149,963
0
$0
$149,963
Warner Gerard H IIIPresident, CooperVision, Inc.
1
$100,384
0
$0
$100,384
Andrews Brian GEVP, CFO & Treasurer
1
$100,162
0
$0
$100,162
Sheffield Holly RPresident, CSI
1
$99,323
0
$0
$99,323
Rivas Mariadirector
1
$82,130
0
$0
$82,130

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Insider Activity of The Cooper Companies, Inc.

Over the last 12 months, insiders at The Cooper Companies, Inc. have bought $2.52M and sold $0 worth of The Cooper Companies, Inc. stock.

On average, over the past 5 years, insiders at The Cooper Companies, Inc. have bought $2.52M and sold $42.88M worth of stock each year.

Highest buying activity among insiders over the last 12 months: White Albert G III (President & CEO) — $1.49M. Kurzius Lawrence Erik (director) — $301,780. McBride Daniel G (EVP & Chief Operating Officer) — $195,120.

The last purchase of 1,784 shares for transaction amount of $149,963 was made by Lucchese Cynthia L (director) on 2025‑12‑22.

List of Insider Buy and Sell Transactions, The Cooper Companies, Inc.

2025-12-22PurchaseLucchese Cynthia Ldirector
1,784
0.0009%
$84.06
$149,963
-1.85%
2025-12-18PurchaseRivas Mariadirector
1,000
0.0005%
$82.13
$82,130
-0.12%
2025-12-17PurchaseKurzius Lawrence Erikdirector
2,000
0.001%
$82.50
$165,000
-0.12%
2025-12-16PurchaseWhite Albert G IIIPresident & CEO
10,000
0.005%
$80.80
$808,000
+1.70%
2025-12-16PurchaseSheffield Holly RPresident, CSI
1,230
0.0006%
$80.75
$99,323
+1.70%
2025-09-29PurchaseKurzius Lawrence Erikdirector
2,000
0.001%
$68.39
$136,780
+18.93%
2025-09-05PurchaseWhite Albert G IIIPresident & CEO
10,000
0.005%
$68.39
$683,900
+14.47%
2025-09-05PurchaseWarner Gerard H IIIPresident, CooperVision, Inc.
1,450
0.0007%
$69.23
$100,384
+14.47%
2025-09-02PurchaseMcBride Daniel GEVP & Chief Operating Officer
3,000
0.0015%
$65.04
$195,120
+18.89%
2025-09-02PurchaseAndrews Brian GEVP, CFO & Treasurer
1,525
0.0008%
$65.68
$100,162
+18.89%
2024-09-19SaleWhite Albert G IIIPresident & CEO
114,992
0.0574%
$110.53
$12.71M
-25.80%
2024-09-10SaleRicupati AgostinoSVP & CAO
1,601
0.0008%
$108.03
$172,955
-22.27%
2024-09-05SaleAndrews Brian GEVP, CFO & Treasurer
24,788
0.0124%
$105.90
$2.63M
-20.20%
2024-09-04SaleMcBride Daniel GEVP & Chief Operating Officer
114,992
0.0577%
$105.48
$12.13M
-18.77%
2024-03-18SaleRicupati AgostinoSVP & CAO
29,528
0.0149%
$100.89
$2.98M
-6.30%
2024-03-08SaleWEISS ROBERT Sdirector
88,075
0.0446%
$102.18
$9M
-6.65%
2024-03-07SaleWEISS ROBERT Sdirector
153,213
0.0772%
$102.21
$15.66M
-7.15%
2024-03-05SalePETERSMEYER GARY Sdirector
1,000
0.0005%
$103.51
$103,506
-6.46%
2024-01-04SalePETERSMEYER GARY Sdirector
150
0.0003%
$336.03
$50,404
+3.97%
2023-12-19SaleWEISS ROBERT Sdirector
79,370
0.1607%
$364.81
$28.96M
+4.11%
Total: 541
*Gray background shows transactions not older than one year

Insider Historical Profitability

15.17%
White Albert G IIIPresident & CEO
236151
0.1205%
$18.08M1010
+29.23%
McBride Daniel GEVP & Chief Operating Officer
63120
0.0322%
$4.83M216
<0.0001%
Sheffield Holly RPresident, CSI
39052
0.0199%
$2.99M30
+25.76%
Andrews Brian GEVP, CFO & Treasurer
22191
0.0113%
$1.7M13
Warner Gerard H IIIPresident, CooperVision, Inc.
18319
0.0093%
$1.4M11
Rivas Mariadirector
11141
0.0057%
$852,843.5510
Lucchese Cynthia Ldirector
9445
0.0048%
$723,014.7510
Kurzius Lawrence Erikdirector
7777
0.004%
$595,329.3520
WEISS ROBERT Sdirector
282772
0.1443%
$21.65M526
+27.93%
MARX MOSESdirector
102932
0.0525%
$7.88M17
<0.0001%
KAUFMAN CAROL REVP, Sec. & Chief Gov. Officer
45943
0.0234%
$3.52M117
+10.48%
PRESS DONALDdirector
42926
0.0219%
$3.29M332
<0.0001%
WHITEFORD STEPHENVP, Corporate Controller
15052
0.0077%
$1.15M03
Matz Gregory WSVP, CFO & CRO
15123
0.0077%
$1.16M04
Lindell Jody Sdirector
13543
0.0069%
$1.04M116
+4.36%
BENDER A THOMASdirector
12471
0.0064%
$954,655.05464
+13.3%
WEBER JOHN ARTHURPresident, CooperVision, Inc.
11995
0.0061%
$918,217.25216
+8%
ROSENBERG STEVENdirector
11460
0.0058%
$877,263.00021
ZINBERG STANLEY MDdirector
10528
0.0054%
$805,918.40229
+12.26%
ACOSTA DAVIDTreasurer
10000
0.0051%
$765,500.0004
PICHOTTA NICHOLAS JPres, CEO Cooper Medical, Inc.
7463
0.0038%
$571,292.65021
FOLDEN RODNEYVP & Corporate Controller
6682
0.0034%
$511,507.1007
KALKSTEIN MICHAELdirector
5838
0.003%
$446,898.90023
PETERSMEYER GARY Sdirector
5668
0.0029%
$433,885.40022
Ricupati AgostinoSVP & CAO
4818
0.0025%
$368,817.9019
+26.76%
NEIL STEVEN MEVP & CFO
4300
0.0022%
$329,165.0030
+3.22%
BATTIN B NORRISVP, Investor Relations
4000
0.002%
$306,200.0023
+11.54%
FRYLING GREGORY APres & COO - CVI
3790
0.0019%
$290,124.50011
RUBENSTEIN ALLAN Edirector
3091
0.0016%
$236,616.05155
+15.96%
CUMMINS EDGAR Jdirector
1764
0.0009%
$135,034.2002
REMMELL PAUL LPres & CEO - CooperSurgical
1352
0.0007%
$103,495.60018
Auerbach Robert DSpecial Advisor to the CEO
1403
0.0007%
$107,374.9203
Golden RandalVP, General Counsel & Sec.
1148
0.0006%
$87,879.4005
KOZY WILLIAM Adirector
770
0.0004%
$58,943.5010
+3.83%
FRUTH JOHN Ddirector
0
0%
$0028
CALCAGNO JOHN JCFO - CooperVision
0
0%
$007
WELCH JAMES MVice President Intl Ops - CVI
0
0%
$001
Midlock Eugene JSr. VP and CFO
0
0%
$013
<0.0001%
McLean Jeffrey AlanExec VP, Comm. Strategies-CVI
0
0%
$002
Sedgwick AndrewPresident, EMEA
0
0%
$001
Murphy DennisPresident Americas, CVI
0
0%
$002
*Gray background shows insiders who have made transactions during last year

COO Institutional Investors: Active Positions

Increased Positions347+47.02%33M+15.98%
Decreased Positions329-44.58%37M-17.81%
New Positions123New12MNew
Sold Out Positions73Sold Out11MSold Out
Total Postitions756+2.44%203M-1.83%

COO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1.94M12.23%23.97M-279,856-1.15%2025-09-30
Blackrock, Inc.$1.24M7.82%15.32M-128,850-0.83%2025-09-30
Capital World Investors$855,840.005.38%10.55M+2M+25.73%2025-09-30
T. Rowe Price Investment Management, Inc.$797,036.005.01%9.83M+2M+33.16%2025-09-30
State Street Corp$696,455.004.38%8.59M-73,189-0.84%2025-09-30
Kayne Anderson Rudnick Investment Management Llc$612,400.003.85%7.55M-304,551-3.88%2025-09-30
Wellington Management Group Llp$501,665.003.16%6.18M+5M+332.88%2025-09-30
Geode Capital Management, Llc$430,103.002.71%5.3M+97,098+1.86%2025-09-30
Invesco Ltd.$358,431.002.26%4.42M-204,864-4.43%2025-09-30
Sustainable Growth Advisers, Lp$335,190.002.11%4.13M+747,476+22.08%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.